Richard C. Becker - Concepedia

Author

Richard C. Becker

Also Known As

ACTIV-4 Host Tissue Investigators, Aneesh Singhal, Becker, Richard, Becker, Richard C, Becker, Richard C., Christopher Rusconi, Kevin J. Anstrom, Lars Wallentin, Pat Keane-Richmond, R BECKER

668

Publications

43.2K

Citations

H-Index

142

Concepts

All Affiliations

Clinical Research Institute Duke Medical Center Heidelberg University University of Cincinnati Medical Center University of Sheffield

About

Richard C. Becker is an author at Clinical Research Institute specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	91	10.6K
2	Health Sciences	6	6	779
3	Education	2	2	83
4	Engineering	1	1	12
5	Natural Sciences	1	1	12

Richard C. Becker

181

Publications

36.2K

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, New England Journal of Medicine	2011	9.3K
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars Wallentin, Richard C. Becker, Andrzej Budaj, New England Journal of Medicine	2009	7K
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa, The Lancet CardiomyopathyStructural Heart DiseaseCardiovascular DiseaseMedicineAnesthesiology	2020	1.1K
The Perioperative Management of Antithrombotic Therapy James D. Douketis, Peter B. Berger, Andrew Dunn, CHEST Journal ThrombosisVenous ThrombosisMedicinePatient SafetyVascular Surgery	2008	834
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial Lars Wallentin, Stefan James, Robert F. Storey, The Lancet ThrombosisCardiovascular DiseaseMedicineGenetic EpidemiologyCardiovascular Pharmacology	2010	794
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Christopher P. Cannon, Robert A. Harrington, Stefan James, The Lancet ThrombosisRandomised Double-blind StudyCardiovascular DiseaseMedicineCoronary Artery Disease	2010	658
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment Keith A.A. Fox, Jonathan P. Piccini, Daniel Wojdyla, European Heart Journal	2011	603
Platelet functions beyond hemostasis Susan S. Smyth, Rodger P. McEver, Andrew S. Weyrich, Journal of Thrombosis and Haemostasis InflammationThrombosisThrombopoiesisHealth SciencesBlood Platelet	2009	565
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Claes Held, Nils Åsenblad, Jean Pierre Bassand, Journal of the American College of Cardiology ThrombosisCardiorenal SyndromesCardiovascular DiseaseCoronary Artery DiseaseVascular Surgery	2010	528
Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention Philippe Gabríel Steg, Stefan James, Robert A. Harrington, Circulation	2010	502

Page 1